Fiera Capital Corp Boosts Stake in Colgate-Palmolive Company $CL

Fiera Capital Corp increased its position in Colgate-Palmolive Company (NYSE:CL) by 1.2% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 887,058 shares of the company’s stock after purchasing an additional 10,338 shares during the quarter. Fiera Capital Corp owned approximately 0.11% of Colgate-Palmolive worth $80,634,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CL. Westside Investment Management Inc. lifted its position in Colgate-Palmolive by 85.5% during the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after buying an additional 130 shares during the period. Saudi Central Bank purchased a new position in Colgate-Palmolive during the 1st quarter valued at about $29,000. Ransom Advisory Ltd bought a new stake in Colgate-Palmolive during the first quarter worth about $33,000. Y.D. More Investments Ltd purchased a new stake in Colgate-Palmolive in the first quarter worth about $37,000. Finally, N.E.W. Advisory Services LLC bought a new position in shares of Colgate-Palmolive during the first quarter valued at approximately $45,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Down 1.1%

CL stock opened at $78.57 on Thursday. The company has a market cap of $63.33 billion, a price-to-earnings ratio of 22.07, a P/E/G ratio of 4.44 and a beta of 0.35. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The business’s 50-day moving average is $79.42 and its two-hundred day moving average is $85.39. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $100.18.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.17 billion. During the same quarter in the prior year, the firm earned $0.91 EPS. The business’s revenue for the quarter was up 1.9% compared to the same quarter last year. As a group, analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be given a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.6%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.26%.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on CL shares. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, October 8th. JPMorgan Chase & Co. dropped their target price on Colgate-Palmolive from $88.00 to $87.00 and set an “overweight” rating on the stock in a report on Monday, November 3rd. Bank of America cut their target price on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Citigroup lowered their price target on Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating for the company in a research report on Monday, November 3rd. Finally, Deutsche Bank Aktiengesellschaft set a $86.00 price target on shares of Colgate-Palmolive in a research note on Friday, October 10th. Nine investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $89.87.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.